COURTESY RHODE ISLAND HOSPITAL 1. Lifespan announces ‘breakthrough’ in brain cancer research POSTED ONLINE: JAN. 6. Lifespan Cancer Institute researchers said the phase 3 trial of the DCVax-L vaccine showed improved survival rates in patients with newly diagnosed and returning glioblastoma, the most common and most lethal form of brain cancer. bit.ly/3jsschH 2.
Already a Subscriber? Log in
To Continue Reading This Article
Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.Learn More and Become a Subscriber
- Critical RI business news and analysis updated daily.
- 1 year of print (26 issues).
- Unlimited access to all subscriber only content on our website, on any device.
- Free email alerts.
- Annual Book of Lists Print Edition.
- All special issues produced during subscription term.
Click Here to purchase a paywall bypass link for this article
PBN Branded Content
Seifert Systems Invests in Energy Efficiency to Strengthen Operations
For manufacturers, energy is more than just another operating expense. It plays a critical role…
Learn More
